Scott Kopetz

79PUBLICATIONS
610CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPredictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (79)

|Jul 29, 2026
COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer.

|Jun 26, 2026
Tumor microbial burden drives immune responses through regulation of Interferon signaling.

|May 18, 2026
EXONERATE-TRaCE: A Liquid Biopsy for Tracking Response to Anti-Epidermal Growth Factor Receptor-Based Therapy in Metastatic Colorectal Cancer.

|May 18, 2026
Glycoprotein Mucin 13 Expression as a Theranostic Target in Colorectal Cancer.

|May 08, 2026
Reprogramming of Cellular Plasticity via ETS and MYC Core-Regulatory Circuits during Response to MAPK Inhibition in BRAF-Mutant Colorectal Cancer.

|Apr 16, 2026
BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings.

Pageof 14

Frequent Collaborators

13 joint publications

John Paul Y C Shen

12 joint publications

Kanwal Raghav

11 joint publications

Van Morris

9 joint publications

Michael Overman